Literature DB >> 21160835

Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biology.

Caroline S Verbeke1.   

Abstract

Intraductal papillary-mucinous neoplasm (IPMN) of the pancreas is a clinically and morphologically distinctive precursor lesion of pancreatic cancer, characterized by gradual progression through a sequence of neoplastic changes. Based on the nature of the constituting neoplastic epithelium, degree of dysplasia and location within the pancreatic duct system, IPMNs are divided in several types which differ in their biological properties and clinical outcome. Molecular analysis and recent animal studies suggest that IPMNs develop in the context of a field-defect and reveal their possible relationship with other neoplastic precursor lesions of pancreatic cancer.

Entities:  

Keywords:  Intraductal papillary mucinous neoplasm; Molecular pathology; Pancreas

Year:  2010        PMID: 21160835      PMCID: PMC2999203          DOI: 10.4240/wjgs.v2.i10.306

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  74 in total

1.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

3.  Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.

Authors:  Benoit Terris; Ekaterina Blaveri; Tatjana Crnogorac-Jurcevic; Melanie Jones; Edoardo Missiaglia; Philippe Ruszniewski; Alain Sauvanet; Nicholas R Lemoine
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases.

Authors:  Yoshifuku Nakayama; Hiroshi Inoue; Yoshihiro Hamada; Morishige Takeshita; Hiroshi Iwasaki; Kensei Maeshiro; Shin-ichi Iwanaga; Hiroki Tani; Shinichirou Ryu; Yohichi Yasunami; Seiyo Ikeda
Journal:  Am J Surg Pathol       Date:  2005-05       Impact factor: 6.394

Review 5.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

6.  Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.

Authors:  Jennifer A Sparr; Prathap Bandipalliam; Mark S Redston; Sapna Syngal
Journal:  Am J Surg Pathol       Date:  2009-02       Impact factor: 6.394

7.  Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.

Authors:  Koji Yoshizawa; Hideo Nagai; Shinji Sakurai; Mitsugu Hironaka; Shojiroh Morinaga; Ken Saitoh; Masashi Fukayama
Journal:  Virchows Arch       Date:  2002-10-12       Impact factor: 4.064

8.  Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Adriana Handra-Luca; Anne Couvelard; Claude Degott; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-02-04       Impact factor: 4.064

Review 9.  Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men.

Authors:  Niki A Ottenhof; Anya N A Milne; Folkert H M Morsink; Paul Drillenburg; Fiebo J W Ten Kate; Anirban Maitra; G Johan Offerhaus
Journal:  Arch Pathol Lab Med       Date:  2009-03       Impact factor: 5.534

10.  Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.

Authors:  Stefan Fritz; Carlos Fernandez-del Castillo; Mari Mino-Kenudson; Stefano Crippa; Vikram Deshpande; Gregory Y Lauwers; Andrew L Warshaw; Sarah P Thayer; A John Iafrate
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969

View more
  3 in total

1.  Intraductal papillary mucinous neoplasm: Coming of age.

Authors:  Charles M Vollmer; Elijah Dixon
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 2.  Early detection and prevention of pancreatic cancer: is it really possible today?

Authors:  Marco Del Chiaro; Ralf Segersvärd; Matthias Lohr; Caroline Verbeke
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression.

Authors:  Rute M M Ferreira; Rocio Sancho; Hendrik A Messal; Emma Nye; Bradley Spencer-Dene; Richard K Stone; Gordon Stamp; Ian Rosewell; Alberto Quaglia; Axel Behrens
Journal:  Cell Rep       Date:  2017-10-24       Impact factor: 9.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.